Eupraxia Pharmaceuticals Inc.

Healthcare

NASDAQ:EPRX · NASDAQ Global Market

Market Cap $216.95M Beta 1.48 P/E (TTM) -8.5

$6.48 +1.11%

+$0.07 today

52W Low $4.19High $9.32

Vol 0.47M · Avg 0.22M

EPS (TTM) -$0.74Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+47.95%

Period High

$9.07

Period Low

$4.31

Latest

$6.48

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

$1.19B

Genfit S.A.

GNFT

$445.68M

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$281.18M

Nautilus Biotechnology, Inc.

NASDAQ:NAUT

$279.57M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$234.97M

Inventiva S.A.

NASDAQ:IVA

$184.19M

Protara Therapeutics, Inc.

NASDAQ:TARA

$156.09M

MediWound Ltd.

NASDAQ:MDWD

$153.32M

Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

$99.18M

Aardvark Therapeutics, Inc. Common Stock

NASDAQ:AARD

$85.52M

What is the latest EPRX filing?

The latest filing shown is 6-K dated May 29, 2026.

How many recent filings does EPRX have?

Intrinsic Alpha currently shows 20 recent filings for EPRX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.